EP 1049489 A1 20001108 - AGENT CAPABLE OF MODULATING A GLYCOSPHINGOLIPID-ASSOCIATED ACTIVITY THUS AFFECTING AN IMMUNE DISORDER
Title (en)
AGENT CAPABLE OF MODULATING A GLYCOSPHINGOLIPID-ASSOCIATED ACTIVITY THUS AFFECTING AN IMMUNE DISORDER
Title (de)
AGENZ FÄHIG ZUR MODULATION EINER GLYCOSPHINGOLIPIDASSOZIIERTEN AKTIVITÄT WODURCH EINE IMMUNSTÖRUNG BEEINFLUSST WIRD
Title (fr)
AGENT CAPABLE DE MODULER L'ACTIVITE LIEE A UN GLYCOSPHINGOLIPIDE, AGISSANT AINSI SUR UN TROUBLE IMMUNITAIRE
Publication
Application
Priority
- GB 9900290 W 19990128
- GB 9801871 A 19980128
Abstract (en)
[origin: WO9938530A1] The use of an agent in the manufacture of a medicament to affect an immune disorder is described. The agent is capable of modulating a glycosphingolipid associated activity. The modulation of the glycosphingolipid associated activity affects an immune disorder.
IPC 1-7
IPC 8 full level
A61K 39/108 (2006.01); A61K 39/39 (2006.01); A61P 37/02 (2006.01); G01N 33/50 (2006.01); G01N 33/92 (2006.01)
CPC (source: EP)
A61K 39/39 (2013.01); A61P 37/02 (2017.12); G01N 33/505 (2013.01); G01N 33/5088 (2013.01); G01N 33/92 (2013.01); A61K 2039/55544 (2013.01); G01N 2405/10 (2013.01)
Citation (search report)
See references of WO 9938530A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9938530 A1 19990805; AU 2290099 A 19990816; CA 2318190 A1 19990805; EP 1049489 A1 20001108; GB 9801871 D0 19980325
DOCDB simple family (application)
GB 9900290 W 19990128; AU 2290099 A 19990128; CA 2318190 A 19990128; EP 99902688 A 19990128; GB 9801871 A 19980128